Biotech company Argos raises $42.5 million in spite of tough market conditions
In spite of the challenging climate to raise capital, a North Carolina biotech company raised $42.5 million for its kidney-focused cancer drug.
Stories of Technology, Innovation, & Entrepreneurship in the Southeast
